Email this article Determination of nitrofurantoin and fosfomycin susceptibility among urinary Escherichia coli isolates
Abstract
Background: Urinary tract infections (UTIs) are one of the most common infections. For treatment of UTIs, there are limited antibiotics due to increased resistance among uropathogens. Two older antibiotics; Nitrofurantoin and Fosfomycin have become novel oral therapeutic options against uropathogens. Aim of the study was to identify UTI causing micro-organisms and evaluate in-vitro activity of nitrofurantoin and fosfomycin against most common isolated organism (E. coli).
Methods: Results of urine samples culture and susceptibility testing over a period of 1 year were analysed and included in this study.
Results: Micro-organisms were isolated from 568 urine samples. Most commonly isolated organism was Escherichia coli (40.50%), followed by Klebsiella spp. (20.07%) and Staphylococcus spp. (17.07%). Susceptibility of E. coli to nitrofurantoin and fosfomycin was 91.74% and 65.65% respectively.
Conclusion: Good activity of nitrofurantoin and fosfomycin against E. coli indicates that these two drugs are potential therapeutic alternatives for urinary tract infections.
Keywords
Full Text:
PDFReferences
Ahmed MA, Shukla GS, Bajaj HK. Incidence of Urinary Tract Infections and determination of their susceptibility to antibiotics among Pregnant Women. Int J Cell Sci Biotechnol. 2016;5:12-6.
Kothari A, Sagar V. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. J Infect Dev. 2008;2(5):354-8.
Pardeshi P. Prevalence of urinary tract infections and current scenario of antibiotic susceptibility pattern of bacteria causing UTI. Indian J Microbiol Res. 2018;5(3):334-8.
Chaudhari VL. Profile and antimicrobial susceptibility pattern of urinary bacterial isolates at a tertiary care hospital in central india Biomedical European of profile and antimicrobial susceptibility pattern of urinary. 2016;3(7):2-6.
Patel H, Soni S, Bhagyalaxmi A, Patel N. Causative agents of urinary tract infections and their antimicrobial susceptibility patterns at a referral center in Western India: An audit to help clinicians prevent antibiotic misuse. J Fam Med Prim Care. 2019;8(1):154.
6. Sardar A, Basireddy SR, Navaz A, Singh M, Kabra V. Comparative evaluation of fosfomycin activity with other antimicrobial agents against E.Coli isolates from urinary tract infections. J Clin Diagnostic Res. 2017;11(2):DC26-DC29.
Gardiner BJ, Stewardson AJ, Abbott IJ, Peleg AY. Nitrofurantoin and fosfomycin for resistant urinary tract infections: Old drugs for emerging problems. Aust Prescr. 2019;42(1):14-9.
Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob. 2007;6:1-7.
Karishetti M, Shaik H. Clinicomicrobial assessment of urinary tract infections in a tertiary care hospital. Indian J Heal Sci Biomed Res. 2019;12(1):69.
Banerjee S, Sengupta M, Sarker T. Fosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogens. Indian J Urol. 2017;33(2):149.
Vijayganapathy S, Karthikeyan V, Mallya A, Mythri K, Viswanatha R, Keshavamurthy R. Antimicrobial resistance patterns in a tertiary care nephro-urology center in South India. J Integr Nephrol Androl. 2018;5(3):93.
Prakash D, Saxena RS. Distribution and Antimicrobial Susceptibility Pattern of Bacterial Pathogens Causing Urinary Tract Infection in Urban Community of Meerut City, India. ISRN Microbiol. 2013;1-13.
Maraki S, Samonis G, Rafailidis PI, Vouloumanou EK, Mavromanolakis E, Falagas ME. Susceptibility of urinary tract bacteria to fosfomycin. Antimicrob Agents Chemother. 2009;53(10):4508-10.
Udayan D, Khan S, Pullanhi U, Kumar A. Fosfomycin as a promising alternative to treat urinary tract infection due to multidrug resistant uropathogens. Turkish J Urol. 2018;44(6):515.
